Everest Organics Ltd - Stock Valuation and Financial Performance

BSE: 524790 | NSE: | Pharmaceuticals & Drugs | Small Cap

Everest Organics Share Price

248.80 1.10 0.44%
as on 21-Feb'25 16:59

DeciZen - make an informed investing decision on Everest Organics

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Fair

3. Price Trend

Everest Organics stock performance -
248.80 116.0087.00% past year

Price Chart, Live Stock Chart, Technical Chart of
P/E Ratio (SA):
0.00
Market Cap:
241.6 Cr.
52-wk low:
110
52-wk high:
307.2

Is Everest Organics Ltd an attractive stock to invest in?

1. Is Everest Organics Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Everest Organics Ltd is a average quality company.

2. Is Everest Organics Ltd undervalued or overvalued?

The key valuation ratios of Everest Organics Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Everest Organics Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Everest Organics Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Everest Organics:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Everest Organics Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE %
15.8%8.9%13.6%13.8%35.3%35.2%33.8%6.3%3.7%6%-
Value Creation
Index
0.1-0.40.00.01.51.51.4-0.6-0.7-0.6-

Growth Parameters

Growth Parameters Colour Code Guide

Sales
10699.5107112156167182200183197171
Sales YoY Gr.
--6.1%7.5%4.9%38.9%7.3%8.6%10.2%-8.5%7.8%-
Adj EPS
2.32.21.51.99.413.416.81-5.20.2-4.3
YoY Gr.
--4.9%-31.9%32%383%42.6%25.9%-94.1%-622.2%NA-
BVPS (₹)
6.317.920.123.432.542.858.258.557.857.369.7
Adj Net
Profit
2.10.71.21.67.510.713.50.8-4.10.1-4
Cash Flow from Ops.
47.19.74.599.713.513.718.416.4-
Debt/CF from Ops.
5.93.91.84.92.41.91.72.82.83.5-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 7.2%4.8%2.8%7.8%
Adj EPS -25%-55.2%-78.4%NA
BVPS27.9%12%-0.5%-0.8%
Share Price - 14.2% 5.1% 89%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
42.312.310.68.933.635.533.31.7-8.90.3-6.7
Op. Profit
Mgn %
7.365.66.311.411.512.63.20.55.63.9
Net Profit
Mgn %
20.71.11.44.86.47.40.4-2.30.1-2.4
Debt to
Equity
4.14.61.11.20.80.50.50.81.11.3-
Working Cap
Days
129147154160128139148167223232243
Cash Conv.
Cycle
-11-16-24-26-16-31029299-25

Recent Performance Summary

No data to display

Return on Equity is Poor

Sales growth has been subdued in last 3 years 2.80%

Debt to equity has increased versus last 3 years average to 1.26

Sales growth is not so good in last 4 quarters at -12.78%

Latest Financials - Everest Organics Ltd.

Standalone Consolidated
TTM EPS (₹) -4.3 -
TTM Sales (₹ Cr.) 171 -
BVPS (₹.) 69.7 -
Reserves (₹ Cr.) 58 -
P/BV 3.57 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 110.00 / 307.15
All Time Low / High (₹) 0.75 / 469.95
Market Cap (₹ Cr.) 242
Equity (₹ Cr.) 9.7
Face Value (₹) 10
Industry PE 37.5

Quarterly Results

 Mar'24 YoY Gr. Rt. %Jun'24 YoY Gr. Rt. %Sep'24 YoY Gr. Rt. %Dec'24 YoY Gr. Rt. %
Sales (₹ Cr.) 52.6 3.732.5 -2444.1 -10.942.1 -19.9
Adj EPS (₹) 0.1 -50-7.6 -191250.9 22001.4 7050
Op. Profit Mgn % 5.63 114 bps-11.27 -1718 bps7.78 231 bps9.56 423 bps
Net Profit Mgn % 0.11 -11 bps-18.77 -1885 bps1.68 162 bps2.71 268 bps

Management X-Ray of Everest Organics:

Shareholding Pattern

JavaScript chart by amCharts 3.21.5
JavaScript chart by amCharts 3.21.5Promoters:74.15%Institutions:0.03%Non-Institutions:25.82%

Promoter's Holding & Share Pledging

JavaScript chart by amCharts 3.21.5Sep22Dec22Mar23Jun23Sep23Dec23Mar24Jun24Sep24Dec240%20%40%60%80%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Everest Organics

MRP
spaceLock icon
MOS
spaceLock icon%
DP
spaceLock icon
Base EPS
spaceLock icon
DPS
spaceLock icon
MRP: ₹ 0
DP: ₹0
Base EPS ₹:
DPS ₹:
MOS (%):
Expected EPS Growth Rate:
0%
Base 0%
50%
Expected Rate of Return:
0%
Base 0%
50%
Future PE:
0
Base 0
200
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max

Event Update

Login/Register to view analysis.

Analyst's Notes

No data found!

Key Ratios of Everest Organics

Adj EPS (Rs.)

Price Chart, Live Stock Chart, Technical Chart of

Sales (Cr.)

ROE (%)

Price Chart, Live Stock Chart, Technical Chart of

ROCE (%)

Company Name CMP(₹)
Change ₹(%)
Market Cap
Net Sales (₹ Cr.)
Latest EPS (₹)
Net Profit Margin %
Latest P/E
Latest P/BV
Alembic Pharma 802.8 -10.6 (-1.3%) Small Cap 6,229 30.8 9.6 26.4 3.2
Laurus Labs 521.1 -15.4 (-2.9%) Small Cap 5,041 3.7 3.1 144.5 6.9
Piramal Pharma 208.6 -9.5 (-4.3%) Small Cap 4,390 5.2 8.4 42.1 4.1
Ajanta Pharma 2,607.3 -63.1 (-2.4%) Small Cap 4,209 71.9 19 37.2 8.5
Gland Pharma 1,524.3 3.9 (0.3%) Small Cap 4,167 68.1 24.8 22.3 2.7
Natco Pharma 797.8 4.8 (0.6%) Small Cap 3,999 104.1 34.5 7.6 2
Granules India 509 -18.4 (-3.5%) Small Cap 3,755 13.3 11.7 39.7 3.9
Emcure Pharma 996.8 5.2 (0.5%) Small Cap 3,498 8.5 4.4 116.8 6.5
JB Chem & Pharma 1,605.5 -25 (-1.5%) Small Cap 3,299 40.4 16.1 40.4 7.7
Sanofi India 5,076.8 -91.3 (-1.8%) Small Cap 2,851 184.4 20.8 28 15.5
Shows rows:

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales10699107112156167182200183197
Operating Expenses 9894101105138148159194182186
Manufacturing Costs17192020252827323432
Material Costs706368709496108136122124
Employee Cost 6799111214151619
Other Costs 55569119111011
Operating Profit 86671819236111
Operating Profit Margin (%) 7.2%5.7%5.6%6.3%11.4%11.5%12.6%3.2%0.5%5.6%
Other Income 1111111271
Interest 3333333335
Depreciation 3323333446
Exceptional Items -1-100000000
Profit Before Tax 2022121417201
Tax 0001534100
Profit After Tax 201281114100
PAT Margin (%) 1.6%0.2%1.3%1.5%4.8%6.5%7.6%0.6%-0.1%0.1%
Adjusted EPS (₹)1.80.51.72.19.413.617.11.4-0.20.2
Dividend Payout Ratio (%)0%0%0%0%11%7%9%35%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 661619263447474646
Share Capital 9388888888
Reserves -33811182639393838
Minority Interest0000000000
Debt22261519191520324653
Long Term Debt111456556111215
Short Term Debt11121013141114213438
Trade Payables354048494956558095111
Others Liabilities 4478131414191417
Total Liabilities 67768694107120135178202227

Fixed Assets

Gross Block4954626673748291101104
Accumulated Depreciation25272932353539424752
Net Fixed Assets24273334383944495452
CWIP 011101081221
Investments 0000000000
Inventories891314182733414744
Trade Receivables293231384144516976100
Cash Equivalents 1111222111
Others Assets458676610129
Total Assets 67768694107120135178202227

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 4710591014141816
PBT 2022121414100
Adjustment 55561467811
Changes in Working Capital -323-3-5-8-76116
Tax Paid 0000000000
Cash Flow From Investing Activity -3-7-8-4-5-6-12-17-16-13
Capex -3-7-8-3-7-7-7-17-14-13
Net Investments 0000000000
Others 000021-50-30
Cash Flow From Financing Activity -20-20-3-3-22-3-3
Net Proceeds from Shares 0080200000
Net Proceeds from Borrowing 0002000000
Interest Paid -3-3-3-3-3-3-3-3-3-5
Dividend Paid 0000000000
Others 13-71-201512
Net Cash Flow 0001100-100
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)33.193.0612.259.8633.6336.2233.962.45-0.390.3
ROCE (%)15.848.913.5513.835.335.2233.766.253.716.03
Asset Turnover Ratio1.751.521.441.41.761.671.621.471.11.06
PAT to CFO Conversion(x)2N/A102.51.130.91114N/AN/A
Working Capital Days
Receivable Days901029810081828494127142
Inventory Days27303640334453597773
Payable Days180221239253191200188180262303

Everest Organics Ltd Stock News

Everest Organics Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Everest Organics on 21-Feb-2025 16:59 is ₹248.8.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Feb-2025 16:59 the market cap of Everest Organics stood at ₹241.6.
The latest P/E ratio of Everest Organics as of 21-Feb-2025 16:59 is 0.00.
The latest P/B ratio of Everest Organics as of 21-Feb-2025 16:59 is 3.57.
The 52-week high of Everest Organics is ₹307.1 and the 52-week low is ₹110.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Everest Organics is ₹171.2 ( Cr.) .

About Everest Organics Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Loading...
Hold on